Preliminary data from an ongoing phase IIb study of no carrier added 131 I-iobenguane (nca-MIBG) in patients with malignant pheochromocytoma (Pheo)

Journal article

Peer reviewed

D. A. Pryma, J. A. Barrett, R. E. Coleman, R. Noto, C. Jimenez, M. H. Pampaloni, A. N. Serafini, R. L. Wahl, L. Kostakoglu, N. D. LaFrance, …

Journal of clinical oncology, Vol.29(15_suppl), pp.e21122-e21122

2011-05-20

Metrics

1 Record Views

Title: Preliminary data from an ongoing phase IIb study of no carrier added 131 I-iobenguane (nca-MIBG) in patients with malignant pheochromocytoma (Pheo)
Creators: D. A. Pryma
J. A. Barrett
R. E. Coleman
R. Noto
C. Jimenez
M. H. Pampaloni
A. N. Serafini
R. L. Wahl
L. Kostakoglu
N. D. LaFrance
J. W. Babich
Publication Details: Journal of clinical oncology, Vol.29(15_suppl), pp.e21122-e21122
Academic Unit: Miller School of Medicine; UMMG Department of Radiology
Language: English
Resource Type: Journal article
Record Identifier: 991031740064202976